There may not be a more significant biological threat than the malevolent release of B. anthracis spores, the causative agent of anthrax disease, over a major metropolis. With the inhalational form approaching 90% mortality, and a spore that can remain infectious for years, protection against this deadly disease is critical. The U.S. anthrax vaccine induces toxin-neutralizing protection in animal models. However, its composition is unknown, its immunogenicity is short-lived, and it does not protect against some strains of B. anthracis. Our preliminary data suggests bacillus near-iron transporter (NEAT) proteins, which function to acquire and import host heme during infection, can protect mice against anthrax disease following vaccination. In this application, we use our molecular understanding of NEAT protein function to create and test a novel vaccine composed of heme transporters. We hypothesize vaccination with bacillus NEAT proteins will induce neutralizing or opsonin-mediated responses to B. anthracis and protect vertebrate hosts from full-blown anthrax after infection with the most highly-virulent strains.
Aim 1 : Determine the mechanism of protection following vaccination with NEAT proteins. Recombinant NEAT domains will be evaluated for efficacy using a murine model of anthrax. Protective antibodies will be evaluated for activity using heme acquisition and opsonin-mediated assays.
Aim 2 : Determine if vaccination with NEAT proteins protects against fully-virulent B. anthracis. NEAT proteins will be evaluated for their ability to protect against fully-virulent B. anthracis using a well-accepted guinea pig model of anthrax under high-containment. Safe antigens will also be constructed by mutagenesis of key residues that mediate NEAT functionality. Since NEAT proteins are conserved in every major genus of Gram-positive pathogenic bacteria, this work also has universal appeal for vaccine development against related species.

Public Health Relevance

The overall purpose of this study is to develop a better and safe vaccine to protect against anthrax disease. Anthrax is caused by B. anthracis, a bacterium that has been weaponized and is harbored by several prominent terrorist groups. A vaccine would be used to protect civilians if exposed to a malicious release of spores or soldiers on the battlefield.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI109465-02
Application #
8967557
Study Section
Vaccines Against Microbial Diseases Study Section (VMD)
Program Officer
Mukhopadhyay, Suman
Project Start
2014-12-01
Project End
2017-11-30
Budget Start
2015-12-01
Budget End
2017-11-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Balderas, Miriam A; Nguyen, Chinh T Q; Terwilliger, Austen et al. (2016) Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun 84:3408-3422
Ma, Li; Gao, Yongjun; Maresso, Anthony W (2015) Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics. J Bacteriol 197:3708-19
Nguyen, Chinh T Q; Shetty, Vivekananda; Maresso, Anthony W (2015) Global metabolomic analysis of a mammalian host infected with Bacillus anthracis. Infect Immun 83:4811-25
Ma, Li; Terwilliger, Austen; Maresso, Anthony W (2015) Iron and zinc exploitation during bacterial pathogenesis. Metallomics 7:1541-54
Nobles, Christopher L; Clark, Justin R; Green, Sabrina I et al. (2015) A dual component heme biosensor that integrates heme transport and synthesis in bacteria. J Microbiol Methods 118:7-17
Pandey, Naresh; Nobles, Christopher L; Zechiedrich, Lynn et al. (2015) Combining random gene fission and rational gene fusion to discover near-infrared fluorescent protein fragments that report on protein-protein interactions. ACS Synth Biol 4:615-24
Chan, Albert H; Yi, Sung Wook; Terwilliger, Austen L et al. (2015) Structure of the Bacillus anthracis Sortase A Enzyme Bound to Its Sorting Signal: A FLEXIBLE AMINO-TERMINAL APPENDAGE MODULATES SUBSTRATE ACCESS. J Biol Chem 290:25461-74
Green, Sabrina I; Ajami, Nadim J; Ma, Li et al. (2015) Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation. Infect Immun 83:3243-56
Terwilliger, Austen; Swick, Michelle C; Pflughoeft, Kathryn J et al. (2015) Bacillus anthracis Overcomes an Amino Acid Auxotrophy by Cleaving Host Serum Proteins. J Bacteriol 197:2400-11
Honsa, Erin S; Maresso, Anthony W; Highlander, Sarah K (2014) Molecular and evolutionary analysis of NEAr-iron Transporter (NEAT) domains. PLoS One 9:e104794